A detailed history of Nuveen Asset Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 69,065 shares of FLGT stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,065
Previous 74,572 7.38%
Holding current value
$1.27 Million
Previous $1.46 Million 2.53%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.6 - $25.06 $107,937 - $138,005
-5,507 Reduced 7.38%
69,065 $1.5 Million
Q2 2024

Aug 09, 2024

SELL
$19.09 - $22.57 $3.27 Million - $3.87 Million
-171,478 Reduced 69.69%
74,572 $1.46 Million
Q1 2024

May 13, 2024

SELL
$21.55 - $29.29 $641,263 - $871,582
-29,757 Reduced 10.79%
246,050 $5.34 Million
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $225,194 - $288,352
9,526 Added 3.58%
275,807 $7.97 Million
Q3 2023

Nov 14, 2023

SELL
$26.74 - $40.81 $3.94 Million - $6.01 Million
-147,176 Reduced 35.6%
266,281 $7.12 Million
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $5.34 Million - $7.63 Million
187,404 Added 82.9%
413,457 $15.3 Million
Q1 2023

May 15, 2023

BUY
$29.39 - $36.27 $3.22 Million - $3.97 Million
109,509 Added 93.96%
226,053 $7.06 Million
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $699,678 - $964,182
23,937 Added 25.85%
116,544 $3.47 Million
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $5.06 Million - $8.5 Million
-133,345 Reduced 59.01%
92,607 $3.53 Million
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $6.28 Million - $8.22 Million
130,924 Added 137.77%
225,952 $12.3 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $367,743 - $709,003
7,377 Added 8.42%
95,028 $5.98 Million
Q4 2021

Feb 14, 2022

SELL
$77.3 - $105.0 $360,140 - $489,195
-4,659 Reduced 5.05%
87,651 $8.82 Million
Q3 2021

Nov 12, 2021

SELL
$74.87 - $110.87 $1.13 Million - $1.67 Million
-15,093 Reduced 14.05%
92,310 $8.3 Million
Q2 2021

Aug 16, 2021

BUY
$66.8 - $100.45 $3.33 Million - $5.01 Million
49,848 Added 86.61%
107,403 $9.91 Million
Q1 2021

May 17, 2021

BUY
$59.3 - $183.85 $444,809 - $1.38 Million
7,501 Added 14.99%
57,555 $5.56 Million
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $555,544 - $933,371
17,915 Added 55.74%
50,054 $2.61 Million
Q3 2020

Nov 16, 2020

BUY
$15.89 - $50.51 $53,342 - $169,562
3,357 Added 11.66%
32,139 $1.29 Million
Q2 2020

Aug 14, 2020

BUY
$8.89 - $18.28 $255,871 - $526,134
28,782 New
28,782 $461,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.